BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11103236)

  • 21. Treatment of gastric cancer in Asia: the missing link.
    Nishida T
    Lancet Oncol; 2009 Nov; 10(11):1027-8. PubMed ID: 19880057
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
    Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The choice of treatment in advanced gastric cancer].
    Pozzo C; Mansueto G
    Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
    [No Abstract]   [Full Text] [Related]  

  • 24. [Second-line chemotherapy in gastric cancer].
    Takiuchi H; Goto M; Kawabe S; Ohta S; Katsu K
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):19-23. PubMed ID: 15675576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy of advanced gastric cancer.
    Rivera F; Vega-Villegas ME; López-Brea MF
    Cancer Treat Rev; 2007 Jun; 33(4):315-24. PubMed ID: 17376598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy for advanced gastric cancer.
    Wagner AD; Unverzagt S; Grothe W; Kleber G; Grothey A; Haerting J; Fleig WE
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004064. PubMed ID: 20238327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy for gastric carcinoma: new and old options.
    Ajani JA
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 7):44-7. PubMed ID: 9830625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
    Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral treatment for gastric cancer: new choices, better choices?
    Cascinu S
    Lancet Oncol; 2008 Mar; 9(3):188-9. PubMed ID: 18308239
    [No Abstract]   [Full Text] [Related]  

  • 30. S-1 in gastric cancer: a comprehensive review.
    Maehara Y
    Gastric Cancer; 2003; 6 Suppl 1():2-8. PubMed ID: 12775012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer.
    Koizumi W; Tanabe S; Azuma M; Ishido K; Nishimura K; Sasaki T; Nakatani K; Higuchi K; Nakayama N; Katada C
    Int J Cancer; 2010 Jan; 126(1):162-70. PubMed ID: 19588501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of chemotherapy using new anti-cancer drugs since S-1 for advanced or recurrent gastric cancer in our institute].
    Sato T; Kikuchi Y; Saito T; Hirano S; Kouzuma T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1819-25. PubMed ID: 18030016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of chemotherapy for outpatients with gastric or colorectal cancer].
    Gotoh M; Kawabe S; Takiuchi H; Ohta S; Katsu K
    Gan To Kagaku Ryoho; 2002 Dec; 29 Suppl 3():470-4. PubMed ID: 12536832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Three successful case reports of advanced gastric cancer with chemotherapy].
    Yamamoto M; Niinobu T; Taniguchi H; Kotobuki T; Fukunaga K; Kawai M
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1689-92. PubMed ID: 15553684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in chemotherapy for colorectal cancer].
    Sasaki T; Maeda Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2185-92. PubMed ID: 11142161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. S-1 for the treatment of gastrointestinal cancer.
    Satoh T; Sakata Y
    Expert Opin Pharmacother; 2012 Sep; 13(13):1943-59. PubMed ID: 22860709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial].
    Inokuchi M; Yamashita T; Yamada H; Kojima K; Sekita Y; Kawano T; Sugihara K
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):875-9. PubMed ID: 17565249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents?
    Pozzo C; Barone C
    Oncologist; 2008 Jul; 13(7):794-806. PubMed ID: 18614586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of multidisciplinary therapy combining neoadjuvant chemotherapy with S-1 plus cisplatin and postoperative sequential chemotherapy in patients with scirrhous gastric cancer.
    Oshima T; Kunisaki C; Sato T; Yamada R; Fujii S; Rino Y; Masuda M; Imada T
    Hepatogastroenterology; 2012; 59(117):1638-42. PubMed ID: 22115800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.